Ho Tony W

CIK 00017136372 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001713637

Recent Transactions

48 trades

Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-11+24,200→ 24,200 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-13+22,383→ 22,383 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-09+17,538→ 17,538 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-12-06$69.17/sh−12,607→ 52,364 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-12-03+26,667→ 13,333 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-12-03+26,667→ 64,971 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-10-15+13,800→ 13,800 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-17+4,560→ 4,560 total
Award
iTeos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-04-29+33,217→ 0 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-03-11+23,334→ 23,334 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2021-03-11+9,000→ 9,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-10+4,583→ 40,445 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-10$124.15/sh−2,141→ 38,304 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-05$114.65/sh−1,585→ 35,862 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2021-03-05+3,333→ 37,447 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (right to buy)
2020-12-21−23,551→ 236,449 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$16.90/sh+23,551→ 57,515 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$150.16/sh−1,600→ 53,315 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$149.18/sh−900→ 54,915 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$151.58/sh−1,100→ 52,215 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$148.38/sh−8,400→ 41,915 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$149.73/sh−5,000→ 36,915 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$148.11/sh−1,700→ 55,815 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$152.41/sh−500→ 51,715 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$147.05/sh−1,400→ 50,315 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-12-21$150.61/sh−2,951→ 33,964 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-10-05+16,666→ 16,666 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-06-23$75.20/sh−6,929→ 33,747 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-06-22$70.14/sh−229→ 40,676 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-05-26$70.14/sh−6,100→ 40,905 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2020-05-22$70.05/sh−600→ 47,005 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-03-10+55,000→ 55,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2020-03-10+13,750→ 13,750 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2020-03-06$52.64/sh−1,563→ 47,605 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2020-03-05+3,333→ 49,168 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2019-12-03+40,000→ 40,000 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2019-08-02$52.56/sh−14,534→ 45,835 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2019-08-01+37,500→ 60,369 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2019-08-01−37,500→ 0 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2019-03-05$40.87/sh+10,000→ 32,869 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-03-05+75,000→ 75,000 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2018-08-02$48.43/sh−14,631→ 22,869 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2018-08-01−37,500→ 37,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2018-08-01+37,500→ 37,500 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-06-15+43,000→ 43,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2018-03-07+53,000→ 53,000 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2017-08-01+75,000→ 75,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Options (Right to Buy)
2017-08-01+260,000→ 260,000 total

Companies

Recent Filings

Address

C/O CRISPR THERAPEUTICS, INC. 610 MAIN ST.

CAMBRIDGE, MA, 02139

View on SEC.gov